| Literature DB >> 27111330 |
Evgenia I Tolstykh1, Marina O Degteva1, Nikolay G Bougrov1, Bruce A Napier2.
Abstract
Long-term whole-body monitoring of radionuclides in residents of the Urals Region has been performed at the Urals Research Center for Radiation Medicine (URCRM, Chelyabinsk). Quantification of 40K was achieved by measuring the 40K photopeak with four phoswich detectors in whole body counter SICH-9.1M. The current study presents the results of 40K measurements in 3,651 women and 1,961 t-test; U-test men aged 11-90; measurements were performed in 2006-2014. The residents belonged to two ethnic groups, Turkic (Tatar, Bashkir) and Slavs (mainly Russian). The levels of 40K-body contents depend upon gender, age, and body mass. Significant ethnic-differences were not found in 40K-body contents and 40K concentrations in terms of Bq per kg of body weight (in groups homogenous by age and gender). Both 40K-body contents and concentrations were significantly higher in men than in women in all age-groups; the difference was about 25%. The measured 40K-body content in men of 20-50 years was about 4200 Bq (134 g of K) and about 3000 Bq (95 g of K) in women. By the age of 80 these values decreased to 3200 Bq (102 g of K) in men and 2500 Bq (80 g of K) in women. Annual dose rates were maximal in the age group of 20-30 years- 0.16 mGy/y for men and 0.13 mGy/y for women. Further, the dose-rates decreased with age and in the groups of 60-80 years were 0.13 mGy/y for men and 0.10 mGy/y for women. Within groups homogeneous by age and gender, individual dose rates are described by a normal statistical distribution. The coefficient of variation ranges from 9 to 14%, and on the average is 12.5%. Doses from naturally occurring 40K accumulated over 70 years were found to be 9.9 mGy for men and 8.3 mGy for women; over 90 years - 12.5 and 10.4 mGy.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27111330 PMCID: PMC4844139 DOI: 10.1371/journal.pone.0154266
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Anthropometric characteristic of persons under study.
| Age range | Age, М±STDV | Number of subjects | Height, mm М±STDV | Weight, kgМ±STDV | Body-mass index, M±STDV |
|---|---|---|---|---|---|
| 16±2.3 | 10 | 1668±113 | 55.3±15 | 19.5±3.0 | |
| 25±2.8 | 36 | 1738±66 | 75.4±18 | 24.9±5.1 | |
| 35±3.1 | 54 | 1757±55 | 82.7±17 | 26.8±5.2 | |
| 45±2.9 | 76 | 1753±55 | 84.6±16 | 27.5±4.9 | |
| 55±3.0 | 209 | 1708±54 | 81.8±15 | 28.0±4.7 | |
| 64±3.0 | 215 | 1694±65 | 79.9±15 | 27.7±4.5 | |
| 73±2.6 | 142 | 1659±60 | 77.6±15 | 28.2±5.1 | |
| 81±1.5 | 13 | 1635±46 | 68.7±10 | 25.8±3.8 | |
| 17.0±2.2 | 21 | 1701±84 | 62.4±11.7 | 21.5±3.0 | |
| 24.2±3.0 | 67 | 1720±71 | 69.5±13.6 | 23.4±4.1 | |
| 35.4±3.1 | 84 | 1713±60 | 78.2±13.4 | 26.7±4.6 | |
| 45.4±2.7 | 196 | 1692±67 | 77.1±14.8 | 26.9±4.5 | |
| 54.6±2.9 | 368 | 1686±57 | 80.9±14.4 | 28.4±4.6 | |
| 64.2±3.2 | 275 | 1667±62 | 77.8±14.4 | 27.9±4.4 | |
| 73.2±2.7 | 178 | 1624±54 | 73.1±11.1 | 27.7±3.9 | |
| 82.4±2.3 | 17 | 1630±42 | 70.7±10.9 | 26.6±4.1 | |
| 16.9±2.6 | 10 | 1614±61 | 54.9±12.3 | 21.0±4.2 | |
| 24.6±3.1 | 48 | 1607±63 | 60.6±14.9 | 23.5±5.7 | |
| 35.1±2.8 | 80 | 1617±59 | 68.7±14.6 | 26.3±5.7 | |
| 45.1±2.8 | 129 | 1608±60 | 75.8±15.1 | 29.4±5.9 | |
| 55.0±2.9 | 417 | 1580±53 | 79.4±16.2 | 31.8±6.6 | |
| 64.2±3.1 | 389 | 1562±53 | 77.3±16.0 | 31.6±6.1 | |
| 73.3±2.7 | 291 | 1530±53 | 73.9±14.3 | 31.5±5.7 | |
| 82.5±2.9 | 32 | 1488±38 | 66.1±11.6 | 29.8±4.7 | |
| 16.8±2.2 | 18 | 1587±55 | 55.9±12.4 | 22.1±4.3 | |
| 24.7±2.8 | 78 | 1608±57 | 57.1±10.3 | 22.1±4.0 | |
| 35.0±2.8 | 136 | 1598±57 | 67.1±14.4 | 26.3±5.7 | |
| 45.5±2.7 | 417 | 1574±59 | 72.8±14.2 | 29.4±5.7 | |
| 54.3±2.8 | 716 | 1560±53 | 74.5±14.1 | 30.6±5.6 | |
| 64.4±3.0 | 518 | 1537±53 | 76.5±13.9 | 32.4±5.6 | |
| 72.9±2.4 | 349 | 1512±51 | 72.4±13.0 | 31.6±5.3 | |
| 82.7±2.5 | 23 | 1508±52 | 67.5±13.3 | 29.6±4.8 |
М±STDV—mean±standard deviation;
*- statistically significant difference between ethnic groups of the same age and gender (p<0.05 t-test; U-test)
Characteristics of phantoms, DF-values and dose coefficients for 40K derived from [12].
| Phantom | DF-value ×10-12 mGy·Bq-1·s-1 | Phantom weight, kg | DC ×10−12 mGy·s-1 (Bq kg-1)-1 | DC mGy year-1 (Bq kg-1)-1 | Patient weight, kg |
|---|---|---|---|---|---|
| Adult male | 1.2 | 73.7 | 88.44 | 0.002791 | 65–85 |
| Adult female | 1.54 | 56.8 | 87.47 | 0.002760 | 45–65 |
| 15 years | 1.54 | 56.8 | 87.47 | 0.002760 | 45–65 |
| 10 years | 2.61 | 33.2 | 86.65 | 0.002734 | 30–45 |
| 5 years | 4.35 | 19.8 | 86.13 | 0.002718 | - |
| 1 year | 8.76 | 9.72 | 85.15 | 0.002687 | - |
| New-born | 23.3 | 3.6 | 83.88 | 0.002647 | - |
Fig 1Dependence of dose coefficient on body weight.
Fig 240K and stable potassium body contends in men and women depending on age gender and ethnicity.
(a) Slavs, total body potassium and 40K; (b) Turkic peoples, total body potassium and 40K; (c) Slavs, body potassium g/kg and 40K Bq/kg; (d) Turkic peoples, body potassium g/kg and 40K Bq/kg. Bars represent the range of standard deviation. *—statistically significant differences from the value for the age group 20–30 of the respective gender (t-test; U-test).
Pearson correlation coefficients for 40K characteristics, age and BMI in different age- groups of men and women.
| Women | Men | |||||
|---|---|---|---|---|---|---|
| -0.15 | 0.71 | 0.20 | -0.14 | 0.70 | 0.13 | |
| - | -0.70 | -0.27 | - | -0.70 | -0.18 | |
| - | - | 0.31 | - | - | 0.22 | |
| 0.04 | 0.57 | -0.3 | 0.20 | 0.59 | -0.42 | |
| - | -0.70 | -0.26 | - | -0.54 | -0.32 | |
| - | - | 0.11 | - | - | 0.03 | |
| 0.03 | 0.62 | -0.31 | 0.21 | 0.60 | -0.28 | |
| - | -0.65 | -0.09 | - | -0.50 | -0.10 | |
| - | - | -0.07 | - | - | -0.025 | |
Comments: in all cases (excepting indicated by *) p<0.001;
*- p<0.05;
**- p>0.05; there is no significant relationship between the two variables.
In 25–40 group n = 313 (women) and n = 203 (men); in 40–80 group n = 3281 (women) and n = 1689 (men); in 60–80 group n = 1602 (women) and n = 840 (men)
Parameters of multiple regressions for two independent variables (age, BMI) which predict specific activity of 40K.
| Group of those aged 40–80 | Coefficient of multiple correlation R2 | Standardized Beta 1 (variable Аge) | Standardized Beta 2 (variable BMI) |
|---|---|---|---|
| 0.402 (p<0.001; F = 568) | -0.293±0.019 (p<0.001) | -0.559±0.019 (p<0.001) | |
| 0.516 (p<0.001; F = 1745) | -0.180±0.012 (p<0.001) | -0.675±0.012 (p<0.001) |
Characteristics of annual dose rates for Urals residents depending on gender and age.
| Age group, years | N | Annual dose rate, mGy М±STDV | CV% | Shapiro-Wilk test | |
|---|---|---|---|---|---|
| W-test | P | ||||
| 28 | 0.131±0.012 | 9 | 0.973 | ||
| 142 | 0.126±0.014 | 11 | 0.984 | ||
| 200 | 0.120±0.015 | 12 | 0.996 | ||
| 546 | 0.113±0.014 | 13 | 0.996 | ||
| 1133 | 0.108±0.014 | 13 | 0.998 | ||
| 907 | 0.103±0.014 | 14 | 0.990 | <0.001 | |
| 640 | 0.102±0.013 | 13 | 0.992 | 0.002 | |
| 55 | 0.100±0.011 | 11 | 0.984 | ||
| 35 | 0.157±0.016 | 10 | 0.955 | ||
| 103 | 0.159±0.020 | 12 | 0.965 | 0.008 | |
| 138 | 0.150±0.018 | 12 | 0.991 | ||
| 272 | 0.144±0.016 | 11 | 0.994 | ||
| 577 | 0.136±0.017 | 13 | 0.997 | ||
| 490 | 0.129±0.017 | 13 | 0.960 | < 0.001 | |
| 320 | 0.128±0.016 | 12 | 0.992 | ||
| 30 | 0.127±0.013 | 10 | 0.962 | ||
a- statistically significant differences with the age group 20–29 of the respective sex (t-test; U-test);
b- statistically significant differences with preceding age group (t-test; U-test),
*—W-test is statistically significant; hypothesis about normal distribution of the values of the variable is rejected, data are not described by normal distribution. In other cases data correspond to normal distribution.
Comparison of the results of 40K measurements for adult persons with published data.
| Group | 40K kBq | K g/kg | Source of information | ||
|---|---|---|---|---|---|
| Women | Men | Women | Men | ||
| 3.1±0.2; n = 248 | 4.2±0.1; n = 2037 | 1.4±0.3 | 1.7±0.3 | Lynch et al [ | |
| 4.1±0.3; n = 47 | 5.2±0.2; n = 192 | 2.0±0.5 | 2.1±0.4 | Gohary et al [ | |
| 2.9±0.4; n = 669 | 4.7±0.7; n = 444 | 1.5±0.2 | 1.9±0.3 | He et al [ | |
| 2.6±0.3; n = 197 | 4.1±0.4; n = 152 | 1.5±0.2 | 1.9±0.3 | ||
| 2.8±0.4; n = 313 | 4.2±0.5; n = 203 | 1.4±0.2 | 1.7±0.2 | Current study | |
a- similar results were presented in [12] Strom et al., 2009 based on measurements performed in 2006–2007
b- data were obtained from 40K measurements; original values presented in mmol were recalculated in compatible units of K and 40K (1 mmol = 39 g potassium; 1 g natural potassium contains 31.29 Bq 40K)
c- data for persons aged 25–40 years were used